This article aims to conduct a comparative analysis of the medical device registration review guidance principles issued by China and the United States in 2023 from the perspectives of quantity and key focuses.The objective is to reveal the differences between the two countries and provide relevant suggestions for improving the system of guidance principles in China based on these differences.
维普
万方数据
